Cargando…
Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease
BACKGROUND: Tegoprazan is a novel, fast‐ and long‐acting potassium‐competitive acid blocker that suppresses gastric acid secretion, which could benefit patients with non‐erosive reflux disease (NERD), a type of gastroesophageal reflux disease. AIM: To evaluate the efficacy and safety profiles of teg...
Autores principales: | Kim, Seung Han, Cho, Kwang Bum, Chun, Hoon Jai, Lee, Sang Woo, Kwon, Joong Goo, Lee, Dong Ho, Kim, Sang Gyun, Jung, Hwoon‐Yong, Kim, Ji Won, Lee, Joon Seong, Park, Hyojin, Choi, Suck Chei, Jee, Sam Ryong, Kim, Hyun‐Soo, Ko, Kwang Hyun, Park, Seun Ja, Lee, Yong Chan, Park, Soo Heon, Kim, Ah Rong, Kim, Eun Ji, Park, Hyun Wook, Kim, Bong Tae, Song, Geun Seog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361733/ https://www.ncbi.nlm.nih.gov/pubmed/34227708 http://dx.doi.org/10.1111/apt.16477 |
Ejemplares similares
-
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis
por: Cho, Yu Kyung, et al.
Publicado: (2022) -
Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
por: Lee, Kwang Jae, et al.
Publicado: (2019) -
Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial
por: Cho, Yu Kyung, et al.
Publicado: (2021) -
La erosión
por: Andrade, Antonio
Publicado: (1975) -
Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer
por: Cho, Yu Kyung, et al.
Publicado: (2020)